Zenotech Laboratories Ltd (BSE: 532039) is a Hyderabad, Telangana-based company in the Biological Products industry. With a market capitalisation of ₹263 Cr, it ranks #2,434 by market cap among the 6,137 Indian listed companies on FinBizNet, and #3 of 5 in Biological Products. At ₹40.31 (as of 25 Oct 2026), the share price is 25.5% below its 52-week high of ₹54.14 and 20.1% above its 52-week low of ₹33.55. The share price is down 20.3% over one year and down 9.0% over three months.
| Current Price | ₹40.31 |
|---|---|
| Market Cap | ₹263 Cr |
| BSE Code | 532039 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Biotechnology |
| Sub-Industry | Biotechnology > Biological Products |
| P/E Ratio | -238.3 |
| Return on Equity | -1.12% |
| Return on Assets | 1.55% |
| 52-Week Range | ₹33.55 – ₹54.14 |
| 1-Year Price Change | -20.3% |
| 3-Month Price Change | -9.0% |
| Beta (1Y) | 0.65 |
| Headquarters | Hyderabad, Telangana |
| Website | zenotechlab.com |
Zenotech Laboratories Limited manufactures and markets pharmaceutical specialty generic injectables in the oncology and anesthesiology markets in India. It offers contract manufacturing services for parenteral depot formulations, ophthalmic, oncology oral and injectables, and general injectables. The company also leases out its biotech facility and equipment. In addition, it provides granulocyte-colony stimulating factor and granulocyte-macrophage colony-stimulating factor products. Zenotech Laboratories Limited was incorporated in 1989 and is based in Hyderabad, India.
1. Pharmaceuticals-This segment engages in the manufacture of pharmaceutical specialty generic injectable products for therapy areas, such as oncology and anesthesiology.
1. Pharmaceuticals-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Biocon Limited | ₹56,860 Cr | 120.9 | 1.15% | ₹4,336 Cr | -9.7% |
| Hester Biosciences Ltd | ₹1,905 Cr | 34.5 | 16.55% | ₹77 Cr | +19.5% |
| Zenotech Laboratories Ltd | ₹263 Cr | -238.3 | -1.12% | — | -20.3% |
| Transgene Biotek Ltd. | ₹19 Cr | -11.5 | -17.96% | ₹0 Cr | -39.2% |
| Hindustan Bio Sciences Ltd | ₹7 Cr | -86.3 | -9.12% | — | -18.7% |
Listed by market capitalisation. Ratios are shown for context only.
Zenotech Laboratories Ltd is trading at ₹40.31, with a market capitalisation of ₹263 Cr.
Zenotech Laboratories Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Biotechnology space (Biotechnology > Biological Products).
Zenotech Laboratories Ltd has a P/E of -238.3 and a return on equity of -1.12%.
Zenotech Laboratories Ltd is listed on the BSE under the scrip code 532039.
Zenotech Laboratories Ltd's share price is down 20.3% over one year and down 9.0% over three months. Its 52-week range is ₹33.55 to ₹54.14.
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.